首页> 外文期刊>Joint Commission Journal on Quality and Patient Safety >Impact of a Series of Interventions in Vancomycin Prescribing on Use and Prevalence of Vancomycin-Resistant Enterococci
【24h】

Impact of a Series of Interventions in Vancomycin Prescribing on Use and Prevalence of Vancomycin-Resistant Enterococci

机译:万古霉素处方中的一系列干预对耐万古霉素肠球菌的使用和流行的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background: In response to vancomycin-resistant bacteria, particularly vancomycin-resistant enterococci (VRE), measures have been recommended to improve on the appropriate use of vancomycin. Methods: Intervention 1 consisted of an automatic 72-hour vancomycin stop order; Intervention 2, a standardized procedure for sampling of blood cultures; and Intervention 3, an interdisciplinary critical care team. Results: After Intervention 1, inappropriate use decreased, particularly in treatment of febrile neutropenia and undocumented gram-positive infections. After Intervention 2, the baseline rate of inappropriately drawn blood cultures (IDBCs) was unchanged, and use in patients with IDBCs was comparable during both periods. Before Intervention 3, 38/55 orders continuing > 72 hours were considered inappropriate versus 24/53 (p < .025) after. After the interventions, hospitalwide vancomycin use was reduced. Yet the overall rate of VRE infection initially decreased but then increased once again over time. Discussion: Despite substantial reduction in hospital-wide vancomycin use, the impact on the overall rate of VRE was inconsistent and ward dependent.
机译:背景:针对耐万古霉素的细菌,特别是耐万古霉素的肠球菌(VRE),已建议采取措施改善对万古霉素的适当使用。方法:干预1包括72小时自动停止万古霉素的治疗;干预2,血液培养物采样的标准化程序;跨学科的重症监护团队Intervention 3。结果:干预1后,不当使用减少了,特别是在治疗发热性中性粒细胞减少和未证明的革兰氏阳性感染中。干预2之后,不适当抽取的血液培养物(IDBC)的基线率没有变化,并且在这两个时期中IDBC患者的使用率相当。在干预3之前,将持续时间超过72小时的38/55个订单视为不合适,而在之后的24/53(p <.025)。干预后,减少了全院万古霉素的使用。但是,VRE的总体感染率最初是下降的,但是随着时间的流逝再次上升。讨论:尽管全院万古霉素的使用量大大减少,但对VRE总体发生率的影响仍然不一致,且受病房的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号